C Hsu Selected Research

C Hsu Research Topics

Disease

11	Neoplasms (Cancer) 12/2023 - 07/2000
5	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 10/2004
4	Sepsis (Septicemia) 12/2001 - 07/2000
2	Liver Neoplasms (Liver Cancer) 11/2012 - 03/2010
2	Lymphoma (Lymphomas) 01/2001 - 07/2000
1	Disease Progression 12/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014
1	Exanthema (Rash) 11/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2014
1	Neutropenia 02/2013
1	Ototoxicity 09/2011
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 01/2009
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2008
1	Alzheimer Disease (Alzheimer's Disease) 09/2008
1	Atrophy 09/2008
1	Kidney Neoplasms (Kidney Cancer) 09/2007
1	Carcinoma (Carcinomatosis) 05/2004
1	Nausea 05/2004
1	Thrombocytopenia (Thrombopenia) 05/2004
1	Vomiting 05/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2002
1	Pain (Aches) 01/2002
1	Complex Regional Pain Syndromes 01/2002
1	Vaccinia 11/2001
1	Colorectal Neoplasms (Colorectal Cancer) 11/2001
1	Neoplasm Metastasis (Metastasis) 11/2001
1	Experimental Melanoma 11/2001
1	Brain Neoplasms (Brain Tumor) 01/2001
1	Familial primary gastric lymphoma 01/2001
1	Anemia 09/2000
1	Dementia (Dementias) 06/2000

Drug/Important Bio-Agent (IBA)

4	Gemcitabine FDA Link 05/2015 - 01/2002
2	Sorafenib (BAY 43-9006)FDA Link 12/2023 - 01/2013
2	Neoplasm Antigens (Tumor Antigens)IBA 08/2009 - 11/2001
2	AntigensIBA 08/2009 - 11/2001
2	Proteins (Proteins, Gene)FDA Link 11/2001 - 02/2001
1	B7-H1 AntigenIBA 12/2023
1	NivolumabIBA 12/2023
1	Lenalidomide (CC 5013)FDA Link 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2015
1	Cetuximab (Erbitux)FDA Link 05/2015
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2013
1	SteroidsIBA 02/2013
1	HexokinaseIBA 01/2013
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 09/2011
1	AminoglycosidesIBA 09/2011
1	Capecitabine (Xeloda)FDA Link 03/2010
1	Bevacizumab (Avastin)FDA Link 03/2010
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2009
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2008
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2007
1	Cytotoxins (Cytolysins)IBA 10/2004
1	PPAR gammaIBA 10/2004
1	Troglitazone (Rezulin)FDA Link 10/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2004
1	Alitretinoin FDA Link 10/2004
1	Leucovorin (Folinic Acid)FDA Link 05/2004
1	Transaminases (Aminotransferases)IBA 05/2004
1	Fluorouracil (Carac)FDA LinkGeneric 05/2004
1	Cisplatin (Platino)FDA LinkGeneric 01/2002
1	Caffeine (No Doz)FDA LinkGeneric 01/2002
1	Nicotine FDA Link 01/2002
1	SmokeIBA 01/2002
1	Protein Isoforms (Isoforms)IBA 12/2001
1	Peptides (Polypeptides)IBA 11/2001
1	CD40 Ligand (CD40L)IBA 11/2001
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2001
1	NF-kappa B (NF-kB)IBA 12/2000
1	Hemoglobins (Hemoglobin)IBA 09/2000
1	AnthraquinonesIBA 07/2000
1	AnthracyclinesIBA 07/2000
1	DNA (Deoxyribonucleic Acid)IBA 07/2000

Therapy/Procedure

4	Therapeutics 10/2017 - 03/2010
4	Drug Therapy (Chemotherapy) 05/2015 - 07/2000
4	Punctures 12/2001 - 07/2000
4	Ligation 12/2001 - 07/2000
2	Surgical Instruments (Clip) 11/2012 - 03/2010
1	Postoperative Care 02/2013
1	Total Parenteral Nutrition 02/2013
1	Immunotherapy 11/2001
1	Radiotherapy 01/2001
1	Adjuvant Chemotherapy 07/2000
1	Activities of Daily Living (ADL) 06/2000
1	Home Nursing (Nursing, Home) 06/2000